MiMedx Group, Inc. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
MiMedx Group, Inc. (MDXG) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $4.36 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-02-25
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $4.36M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $3.93M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $3.27M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $3.15M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost |
|---|---|
| 2025-12-31 | $4.36M 10-K · filed 2026-02-25 |
| 2024-12-31 | $3.93M 10-K · filed 2026-02-25 |
| 2023-12-31 | $3.27M 10-K · filed 2025-02-26 |
| 2022-12-31 | $3.15M 10-K · filed 2024-02-28 |
| 2021-12-31 | $4.22M 10-K · filed 2023-02-28 |
| 2020-12-31 | $3.26M 10-K · filed 2022-02-28 |
| 2019-12-31 | $3.44M 10-K · filed 2021-03-08 |
| 2018-12-31 | $3.42M 10-K · filed 2020-07-06 |
| 2017-12-31 | $4.89M 10-K · filed 2020-03-17 |
| 2016-12-31 | $7.42M 10-K · filed 2017-03-01 |
| 2015-12-31 | $7.06M 10-K · filed 2017-03-01 |
| 2014-12-31 | $4.16M 10-K · filed 2017-02-22 |
| 2013-12-31 | $2.15M 10-K · filed 2015-03-13 |
| 2012-12-31 | $213.00K 10-K · filed 2014-03-04 |
| 2011-12-31 | $0.00 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |